Prise en charge de l’asthme et de la BPCO en situation de pandémie de COVID-19 [Asthma and COPD management during the COVID-19 pandemic]
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_798F90DE5822
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Prise en charge de l’asthme et de la BPCO en situation de pandémie de COVID-19 [Asthma and COPD management during the COVID-19 pandemic]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
06/05/2020
Peer-reviewed
Oui
Volume
16
Number
692
Pages
933-938
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.
Keywords
Asthma/complications, Asthma/therapy, Betacoronavirus, Coronavirus Infections/complications, Coronavirus Infections/epidemiology, Humans, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/epidemiology, Pulmonary Disease, Chronic Obstructive/complications, Pulmonary Disease, Chronic Obstructive/therapy, Risk Factors
Pubmed
Create date
16/06/2020 15:32
Last modification date
19/08/2022 7:11